Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRPX2 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | PLXNB3 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-05 |
mRNA | INPP5F | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-05 |
mRNA | GJB2 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | MOB3C | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | PTAFR | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | S100A11 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
mRNA | MICALL1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
mRNA | SLC6A14 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | CTNND1 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-05 |